Latest AI and machine learning research in skin cancer for healthcare professionals.
Skin cancer represents a significant global public health issue, and prompt and precise detection is essential for effective treatment. This study introduces SkinEHDLF, an innovative deep-learning model that enhances skin cancer classification. SkinEHDLF utilizes the advantages of several advanced models, i.e., ConvNeXt, EfficientNetV2, and Swin Transformer, while integrating an adaptive attention...
Melanoma skin cancer is a deadly disease with a high mortality rate. A prompt diagnosis can aid in the treatment of the disease and potentially save the patient's life. Artificial intelligence methods can help diagnose cancer at a rapid speed. The literature has employed numerous Machine Learning (ML) and Deep Learning (DL) algorithms to detect skin cancer. ML algorithms perform well for small dat...
PURPOSE: Anti-PD-1 antibodies are widely used for cancer treatment, including in advanced renal cell carcinoma (RCC). However, the therapeutic respons...
BACKGROUND: Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best pra...
Digital pathology (DP) has significantly transformed breast pathology at Mount Sinai Hospital by enhancing diagnostic accuracy, collaboration, and edu...
Artificial intelligence (AI) has revolutionized various biomedical fields, particularly immunology, by enhancing vaccine development, immunotherapies,...
Lung cancer remains the leading cause of cancer-related deaths globally, often detected in advanced stages with poor prognosis. While surgical resecti...
Cancer remains the second leading cause of death worldwide, representing a substantial challenge to global health. Although traditional risk predictio...
Major depressive disorder (MDD) is a multifactorial disorder involving genetic and environmental factors, with unclear pathogenesis. This study aims t...
Immune checkpoint inhibitors (ICIs) have transformed melanoma treatment; however, predicting patient responses remains a significant challenge. This s...
Programmed death-ligand 1 (PD-L1) is an important biomarker increasingly used as a predictive marker in breast cancer immunotherapy. Immunohistochemic...
BACKGROUND: In recent years, significant progress has been made in the treatment of nasopharyngeal carcinoma (NPC). The application of immunotherapy, ...
Nano-immunotherapy shows great promise in improving patient outcomes, as seen in advanced triple-negative breast cancer, but it does not cure the dise...
The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, a...
Non-invasive diagnostic monitoring techniques have become essential for treating lung cancer (LC), which continues to be the primary cause of cancer-r...
The high morbidity and mortality of hepatocellular carcinoma (HCC) impose a substantial economic burden on patients' families and society, and the maj...
Chimeric antigen receptor (CAR) T cell immunotherapy represents a breakthrough in the treatment of hematological malignancies, but poor specificity ha...
Over the past several decades, there has been a significant increase in the number of breast cancer patients. Among the four subtypes of breast cancer...
MXenes and their composites exhibit remarkable electrical conductivity, mechanical flexibility, and biocompatibility, making them ideal candidates for...
Ovarian cancer (OV) remains the most lethal gynecological malignancy. The aim of this study was to identify molecular subtypes of OV through integrati...